Cerevel Therapeutics (NASDAQ:CERE – Free Report) had its price objective upped by Mizuho from $25.00 to $45.00 in a report issued on Friday morning, Benzinga reports. Mizuho currently has a neutral rating on the biotechnology company’s stock. A number of other equities analysts also recently commented on the company. Jefferies Financial Group reiterated a hold […]
Form PRER14A Cerevel Therapeutics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) have been given a consensus recommendation of “Hold” by the eleven research firms that are currently covering the firm, Marketbeat Ratings reports. Nine investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The […]
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) CFO Susan Altschuller sold 13,808 shares of Cerevel Therapeutics stock in a transaction on Wednesday, December 20th. The shares were sold at an average price of $41.42, for a total value of $571,927.36. Following the completion of the transaction, the chief financial officer now owns 16,913 […]
Mural Oncology Launches To Advance Pipeline Of Novel Engineered Cytokine Immunotherapies menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.